465 Radiotherapy and CTLA-4 blockade expand anti-tumor T cells differentiation states and cooperate with CD40 agonist to induce tumor rejection

Similar Items

• Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
  by: Nils-Petter Rudqvist, et al.
  Published: (2023-08-01)
• 860 CD40 agonism is required to promote the function of cross-presenting dendritic cells and increase triple negative breast cancer response to radiation and CTLA4 inhibition
  by: Xi Zhou, et al.
  Published: (2023-11-01)
• Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.
  by: Michael A Curran, et al.
  Published: (2011-04-01)
• CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response
  by: Maud Charpentier, et al.
  Published: (2023-12-01)
• Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.
  by: W Joost Lesterhuis, et al.
  Published: (2013-01-01)